276 related articles for article (PubMed ID: 2017156)
1. In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells.
Dong ZY; Ward NE; Fan D; Gupta KP; O'Brian CA
Mol Pharmacol; 1991 Apr; 39(4):563-9. PubMed ID: 2017156
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C levels and protein phosphorylation associated with inhibition of proliferation in a murine macrophage tumor.
Goode NT; Hart IR
J Cell Physiol; 1990 Mar; 142(3):480-7. PubMed ID: 2312612
[TBL] [Abstract][Full Text] [Related]
3. The tumor promoter receptor protein kinase C: a novel target for chemoprevention and therapy of human colon cancer.
O'Brian CA; Ward NE; Gravitt KR; Gupta KP
Prog Clin Biol Res; 1995; 391():117-20. PubMed ID: 8532710
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C in adriamycin action and resistance in mouse sarcoma 180 cells.
Posada J; Vichi P; Tritton TR
Cancer Res; 1989 Dec; 49(23):6634-9. PubMed ID: 2819714
[TBL] [Abstract][Full Text] [Related]
5. Selection and preliminary characterization of variant lines of a murine macrophage tumor resistant to the antiproliferative effects of phorbol esters.
Goode NT; Moore JP; Hart IR
Cancer Res; 1990 Mar; 50(5):1510-5. PubMed ID: 2105841
[TBL] [Abstract][Full Text] [Related]
6. Decursin and PDBu: two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells.
Kim HH; Ahn KS; Han H; Choung SY; Choi SY; Kim IH
Leuk Res; 2005 Dec; 29(12):1407-13. PubMed ID: 15992925
[TBL] [Abstract][Full Text] [Related]
7. Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells.
Dale IL; Bradshaw TD; Gescher A; Pettit GR
Cancer Res; 1989 Jun; 49(12):3242-5. PubMed ID: 2720677
[TBL] [Abstract][Full Text] [Related]
8. Evidence that protein kinase C-alpha activation is a critical event in phorbol ester-induced multiple drug resistance in human colon cancer cells.
Gravitt KR; Ward NE; Fan D; Skibber JM; Levin B; O'Brian CA
Biochem Pharmacol; 1994 Jul; 48(2):375-81. PubMed ID: 8053934
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.
Basu A; Weixel K; Saijo N
Cell Growth Differ; 1996 Nov; 7(11):1507-12. PubMed ID: 8930400
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate.
Schwartz GK; Arkin H; Holland JF; Ohnuma T
Cancer Res; 1991 Jan; 51(1):55-61. PubMed ID: 1824824
[TBL] [Abstract][Full Text] [Related]
11. Proliferation of human breast cancer cells and anti-cancer action of doxorubicin and vinblastine are independent of PKC-alpha.
Liu DS; Krebs CE; Liu SJ
J Cell Biochem; 2007 May; 101(2):517-28. PubMed ID: 17171646
[TBL] [Abstract][Full Text] [Related]
12. Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx.
Drew L; Groome N; Warr JR; Rumsby MG
Oncol Res; 1996; 8(6):249-57. PubMed ID: 8895200
[TBL] [Abstract][Full Text] [Related]
13. Role of protein kinase C in the modulation of multidrug resistance: expression of the atypical gamma isoform of protein kinase C does not confer increased resistance to doxorubicin.
Ahmad S; Trepel JB; Ohno S; Suzuki K; Tsuruo T; Glazer RI
Mol Pharmacol; 1992 Dec; 42(6):1004-9. PubMed ID: 1362242
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of chemotactic peptide-induced phosphoinositide hydrolysis by phorbol esters through the activation of protein kinase C in differentiated human leukemia (HL-60) cells.
Kikuchi A; Kozawa O; Hamamori Y; Kaibuchi K; Takai Y
Cancer Res; 1986 Jul; 46(7):3401-6. PubMed ID: 3011248
[TBL] [Abstract][Full Text] [Related]
15. sn-1,2-diacylglycerols and phorbol diesters: uptake, metabolism, and subsequent assimilation of the diacylglycerol metabolites into complex lipids of cultured cells.
Welsh CJ; Cabot MC
J Cell Biochem; 1987 Nov; 35(3):231-45. PubMed ID: 3693423
[TBL] [Abstract][Full Text] [Related]
16. Similar effects of phospholipase C and phorbol ester tumor promoters on primary mouse epidermal cells.
Jeng AY; Lichti U; Strickland JE; Blumberg PM
Cancer Res; 1985 Nov; 45(11 Pt 2):5714-21. PubMed ID: 3931907
[TBL] [Abstract][Full Text] [Related]
17. Rapid inhibition of intercellular communication between BALB/c 3T3 cells by diacylglycerol, a possible endogenous functional analogue of phorbol esters.
Enomoto T; Yamasaki H
Cancer Res; 1985 Aug; 45(8):3706-10. PubMed ID: 3160457
[TBL] [Abstract][Full Text] [Related]
18. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.
Scala S; Dickstein B; Regis J; Szallasi Z; Blumberg PM; Bates SE
Clin Cancer Res; 1995 Dec; 1(12):1581-7. PubMed ID: 9815959
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of MCF-7 cell growth by 12-O-tetradecanoylphorbol-13-acetate and 1,2-dioctanoyl-sn-glycerol: distinct effects on protein kinase C activity.
Issandou M; Bayard F; Darbon JM
Cancer Res; 1988 Dec; 48(23):6943-50. PubMed ID: 3180102
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C down-regulation, and not transient activation, correlates with melanocyte growth.
Brooks G; Wilson RE; Dooley TP; Goss MW; Hart IR
Cancer Res; 1991 Jun; 51(12):3281-8. PubMed ID: 2040003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
